<DOC>
	<DOCNO>NCT01537133</DOCNO>
	<brief_summary>There new , sensitive method detect bacteria . These method show hundred million microbe ( organism see microscope ) , especially bacteria , live healthy people . The collection different microbe find site call `` microbiome . '' The investigator know microbiomes skin , sinus , mouth , gastro-intestinal tract , etc . differ . The make-up microbiome - bacteria find site - may necessary good health . For example , microbiome mouth different people inflammation gum ( periodontitis ) , microbiome bowel different people inflammation intestinal tract ( inflammatory bowel disease ) . The purpose research study find microbiome lung different healthy people without asthma compare people asthma . This study also find microbiome lung change people asthma take daily `` controller '' medication call inhaled corticosteroid .</brief_summary>
	<brief_title>Airway Microbiome Asthma : Relationships Asthma Phenotype Inhaled Corticosteroid Treatment</brief_title>
	<detailed_description>Two broad specific aim study : 1 ) To evaluate whether microbiota bronchial airway atopic asthmatic atopic healthy control differ microbial diversity , richness , evenness , composition specific bacterial taxon . 2 ) To determine whether inhaled corticosteroid treatment alters bronchial microbial community composition asthmatic .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Asthmatic : History physiciandiagnosed asthma . Methacholine PC20 &lt; 8mg/ml and/or FEV1 improvement ≥ 12 % response 180 mcg albuterol . FEV1 ≥ 70 % predict 180 mcg albuterol . Stable asthma ≥ 3 month prior enrollment ( urgent care visit , systemic corticosteroid treatment ) . Asthma Control Questionnaire 6 Score &lt; 1.5 . Able provide inform consent . Able perform spirometry per ATS criterion . Evidence allergen skin test sensitivity aeroallergen . Willingness , female able conceive , utilize one medicallyacceptable form contraception . Healthy Control : Evidence allergen skin test sensitivity aeroallergen . Able provide inform consent . Able perform spirometry per ATS criterion . Asthmatic : Presence lung disease asthma . Use &gt; 10 dos nasal corticosteroid previous 3 month . Presence significant medical illness chronic disease whose treatment could affect clinical feature measure , responses therapy give study , risk participate study . History atrial ventricular tachyarrhythmia . Changes suggestive cardiac ischemia ECG baseline . History upper respiratory infection , sinusitis , bronchitis , antibiotic use previous 3 month . History chronic sinus disease . Smoking &gt; 5 packyears , within past year History longterm controller medication use asthma ( inhaled oral corticosteroid , leukotriene pathway antagonist , cromolyn , theophylline within precede 6 month . History bleed disorder . Reduced creatinine clearance . Inability , opinion Study Investigator , coordinate use inhaler otherwise comply medication regimen . Contraindication bronchoscopy history examination . Healthy Control : History chronic respiratory disease include asthma . Presence significant medical illness chronic disease whose treatment could affect clinical feature measure , responses therapy give study , risk participate study . History atrial ventricular tachyarrhythmia . Changes suggestive cardiac ischemia ECG baseline . History upper respiratory infection , sinusitis , bronchitis , antibiotic use previous 3 month . Methacholine PC20 &lt; 16 mg/ml FEV1 improvement ≥ 12 % response albuterol . History chronic sinus disease Smoking &gt; 5 packyears , within past year Use &gt; 10 dos nasal corticosteroid preparation previous 3 month FEV1 FVC &lt; 80 % predict . History bleed disorder . Reduced creatinine clearance . Contraindication bronchoscopy history examination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>